Accelerate Diagnostics Cash Flow - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$23.1 $0.45 (1.91%) AXDX stock closing price Mar 29, 2017 (Closing)

The Accelerate Diagnostics cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the Accelerate Diagnostics debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Accelerate Diagnostics revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Accelerate Diagnostics stock analysis. Accelerate Diagnostics generated $-53.41M cash from operating activities in 2016-Q4. Accelerate Diagnostics has a negative cash and cash equivalents change of $-101.34M. View details of Accelerate Diagnostics cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.73M2M1.27M0.58M1.98M1.34M0.83M0.37M1.15M0.82M
Net Increase (Decrease) in Assets Liabilities1.54M1.12M-0.25M-0.39M--0.24M-0.22M-0.09M1.36M0.01M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.7M6.5M3.83M1.68M8.38M5.99M4.18M1.65M9.62M7.33M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-2.41M-2.3M-2.08M-1.68M-3.65M-2.59M-2.16M-1.19M-1.93M-1.35M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-47.16M-49.91M-53.15M-32.81M0.98M-0.97M-0.06M1.95M-1.43M-2.36M
Other Cash Inflow (Outflow) from Investment Activities----------
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares1.72M0.94M0.09M0.02M104.97M0.54M0.32M0.06M45.79M45.6M
Issuance (Repayment) of Debt Securities-0.01M-0.01M-0.01M-0.01M-0.14M-0.11M-0.07M-0.03M-0.1M-0.07M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities0.05M0.05M0.17M-0.81M------
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.13M-0.01M--0.04M------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year120.59M53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End19.24M28.73M37.51M72.03M120.58M25.19M35.23M47.39M53.56M57.85M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Accelerate Diagnostics stock price history provides insight into historical stock price fluctuations, and Accelerate Diagnostics stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Accelerate Diagnostics saw a decrease in Net Change in Cash and Cash Equivalents from $-91.85M in 2016-Q3 to $-101.34M in 2016-Q4. Apart from the Accelerate Diagnostics stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Accelerate Diagnostics decreased its cash from operating activities to $12.81M in 2016-Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-53.41M for AXDX in last quarter report.
  • Cash flow from financing activities shows the flow of cash between Accelerate Diagnostics and its owners and creditors and was $1.76M for 2016-Q4. Financing activities allow a company to raise capital, and repay bondholders.